| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| EXELON 13,3 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64475004 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 13,3 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64475005 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 13,3 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64475006 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 13,3 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64475007 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 13,3 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64475008 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 4,6 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64473001 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 4,6 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64473002 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 4,6 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64473003 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 4,6 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64473004 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 4,6 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64473005 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 9,5 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64474001 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 9,5 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64474002 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 9,5 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64474003 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 9,5 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64474004 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXELON 9,5 mg/24h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W64474005 | NOVARTIS EUROPHARM LIMITED - IRLANDA | X | |||||
| EXEMESTAN ACCORD 25 mg | EXEMESTANUM | COMPR. FILM. | L02BG06 | W65803001 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIA | ||||||
| EXEMESTAN ACCORD 25 mg | EXEMESTANUM | COMPR. FILM. | L02BG06 | W65803002 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIA | ||||||
| EXEMESTAN ACCORD 25 mg | EXEMESTANUM | COMPR. FILM. | L02BG06 | W65803003 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIA | ||||||
| EXEMESTAN ACCORD 25 mg | EXEMESTANUM | COMPR. FILM. | L02BG06 | W65803004 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIA | ||||||
| EXEMESTAN ACCORD 25 mg | EXEMESTANUM | COMPR. FILM. | L02BG06 | W65803005 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman